Renaud A Du Pasquier
Overview
Explore the profile of Renaud A Du Pasquier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
2138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oechtering J, Schaedelin S, Stein K, Maceski A, Melie-Garcia L, Benkert P, et al.
Neurol Neuroimmunol Neuroinflamm
. 2025 Jan;
12(2):e200361.
PMID: 39752618
Background And Objectives: Levels of activated complement proteins in the CSF are increased in people with multiple sclerosis (MS) and are associated with clinical disease severity. In this study, we...
2.
Fischer E, Renaud A, Grivaz P, Di Liberto G, Ryvlin P, Cavassini M, et al.
Brain Commun
. 2024 Dec;
7(1):fcae399.
PMID: 39726816
Neurocognitive impairment (NCI) is present in around 40% of people with HIV and substantially affects everyday life, adherence to combined antiretroviral therapy (cART) and overall life expectancy. Suboptimal therapy regimen,...
3.
Blant J, De Rossi N, Gold R, Maurousset A, Kraemer M, Romero-Pinel L, et al.
Neurol Neuroimmunol Neuroinflamm
. 2024 Jul;
11(5):e200281.
PMID: 38991170
Background And Objectives: Progressive multifocal leukoencephalopathy (PML) is a severe neurologic disease resulting from JC virus reactivation in immunocompromised patients. Certain multiple sclerosis (MS) disease-modifying therapies (DMTs) are associated with...
4.
Borrelli S, Martire M, Stolting A, Vanden Bulcke C, Pedrini E, Guisset F, et al.
Neurol Neuroimmunol Neuroinflamm
. 2024 May;
11(4):e200253.
PMID: 38788180
Background And Objectives: The diagnosis of multiple sclerosis (MS) can be challenging in clinical practice because MS presentation can be atypical and mimicked by other diseases. We evaluated the diagnostic...
5.
Oechtering J, Stein K, Schaedelin S, Maceski A, Orleth A, Meier S, et al.
Neurol Neuroimmunol Neuroinflamm
. 2024 Feb;
11(2):e200212.
PMID: 38354323
Background And Objectives: Histopathologic studies have identified immunoglobulin (Ig) deposition and complement activation as contributors of CNS tissue damage in multiple sclerosis (MS). Intrathecal IgM synthesis is associated with higher...
6.
Cagol A, Benkert P, Melie-Garcia L, Schaedelin S, Leber S, Tsagkas C, et al.
Neurology
. 2024 Jan;
102(1):e207768.
PMID: 38165377
Background And Objectives: Progression independent of relapse activity (PIRA) is a crucial determinant of overall disability accumulation in multiple sclerosis (MS). Accelerated brain atrophy has been shown in patients experiencing...
7.
Born T, Vassallo P, Golshayan D, Di Liberto G, Brouland J, Egervari K, et al.
Neurology
. 2023 Jul;
101(13):e1382-e1386.
PMID: 37407265
Progressive multifocal leukoencephalopathy (PML) is a severe infection of the CNS occurring in immunocompromised individuals in which large demyelinating lesions are induced by polyomavirus JC (JCV). In the absence of...
8.
Mathias A, Pantazou V, Perriot S, Canales M, Jones S, Oberholster L, et al.
Neurol Neuroimmunol Neuroinflamm
. 2023 Jan;
10(2).
PMID: 36717268
Background And Objective: Depleting CD20 B cells is the primary mechanism by which ocrelizumab (OCRE) is efficient in persons with multiple sclerosis (pwMS). However, the exact role of OCRE on...
9.
Bernard-Valnet R, Favre E, Bernini A, Oddo M, Chiche J, Du Pasquier R, et al.
Neurology
. 2022 Nov;
99(20):e2326-e2335.
PMID: 36376086
Background And Objectives: Neurologic complications have been associated with COVID-19, including delirium. Such complications have been reported to be frequent among intensive care unit (ICU)-admitted patients. We hypothesized that the...
10.
Bernard-Valnet R, Moisset X, Maubeuge N, Lefebvre M, Ouallet J, Roumier M, et al.
Neurol Neuroimmunol Neuroinflamm
. 2021 Nov;
9(1).
PMID: 34728496
Background And Objectives: Progressive multifocal leukoencephalopathy (PML) is a disabling neurologic disorder resulting from the infection of the CNS by JC polyomavirus in immunocompromised individuals. For the last 2 decades,...